Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Osteosarcoma × camrelizumab × Clear all

Phase

Status

Unknown 2 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Hepatocellular 8 Nasopharyngeal Carcinoma 6 Triple Negative Breast Neoplasms 5 Squamous Cell Carcinoma of Head and Neck 5 Breast Neoplasms 5 Uterine Cervical Neoplasms 4 Colorectal Neoplasms 4 Pancreatic Neoplasms 3 Liver Neoplasms 3 Esophageal Neoplasms 3 Stomach Neoplasms 2 Neoplasm Metastasis 2 Carcinoma, Non-Small-Cell Lung 2 Unresectable Gallbladder Cancer 1 Sarcoma 1 Salivary Gland Neoplasms 1 Recurrence 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Osteosarcoma 1 Non Squamous Non Small Cell Lung Cancer 1 Nasopharyngeal Neoplasms 1 Multiple Primary Lung Cancer 1 Melanoma 1 Lymphoma, Non-Hodgkin 1 Locally Advanced or Metastatic Solid Tumors 1 Locally Advanced Rectal Cancer 1 Liver Diseases 1 Leukemia, Myeloid, Acute 1 Her-2 Negative Breast Cancer 1

Interventions

fludarabine 5 Cyclophosphamide 5 Temozolomide 4 cabozantinib 3 Zoledronic Acid 3 Gemcitabine 3 Doxorubicin 3 irinotecan sucrosofate 2 atezolizumab 2 Vincristine 2 Sunitinib 2 Specimen Handling 2 Radiosurgery 2 Methotrexate 2 Irinotecan 2 Ifosfamide 2 Disulfiram 2 Cisplatin 2 Biopsy 2 vactosertib 1 trametinib 1 talazoparib 1 surufatinib 1 silmitasertib 1 selinexor 1 regorafenib 1 penpulimab 1 pegylated granulocyte colony-stimulating factor 1 pegfilgrastim 1 pazopanib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06074692 2023-10-31

PRIMA

Ruijin Hospital

Phase 2 Recruiting

Sarcoma, Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡